‘Exopharm is not limited to singular potential transactions’…well this much is true. It hasn’t been limited by any transactions to date….
- Forums
- ASX - By Stock
- TYP
- Ann: Business Update
Ann: Business Update, page-8
-
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
0.007(14.9%) |
Mkt cap ! $66.23M |
Open | High | Low | Value | Volume |
4.8¢ | 5.7¢ | 4.7¢ | $523.5K | 10.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6200 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 150000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6200 | 0.054 |
2 | 137000 | 0.053 |
3 | 307255 | 0.052 |
2 | 58035 | 0.051 |
3 | 342718 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 100000 | 1 |
0.056 | 50000 | 1 |
0.057 | 300000 | 1 |
0.058 | 200000 | 1 |
0.059 | 298803 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online